Trial intelligence / Profile preview

VENEZE Peptide Factor Hair Serum vs Minoxidil for Pattern Hair Loss

NCT07536100Recruiting

Sponsor
St John's Institute of Dermatology
Start
May 2026
Primary completion
Nov 2026
Countries
1
01

Overview

Randomised, double-blind trial in androgenetic alopecia (AGA) (2 arms), sponsored by St John's Institute of Dermatology. Primary endpoint: Change in hair density from baseline at 24 weeks. Started May 2026; status: recruiting.

02

Conditions

androgenetic alopecia (AGA)

Beyond the preview

Go deeper on NCT07536100.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07536100.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call